Labshake search

1 - 4 of 4 citations for Irgarol d9 tert butyl d9 since 2020

• Utilizing an acute hyperthermia-induced seizure test and pharmacokinetic studies to establish optimal dosing regimens in a mouse model of Dravet syndrome

  Jeffrey A. Mensah, et al., bioRxiv - Pharmacology and Toxicology 2023

  Quote: ... STP and STP-d9 were purchased as reference powders from Toronto Research Chemicals (Toronto, Canada)
• Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal Cannabis smoke exposure

  Tallan Black, et al., bioRxiv - Pharmacology and Toxicology 2023

  Quote: ... where 6α-OH-CBD and 7-OH-CBD and 7-OH-CBD-D9 were purchased from Toronto Research Chemicals and diluted to 1 mg/mL and stored at -20 ° ...
• A critical role for Pol II CTD phosphorylation in heterochromatic gene activation

  Amoldeep S. Kainth, Hesheng Zhang, David S. Gross, bioRxiv - Genetics 2024

  Quote: ... then 1-NM-PP1 (4-amino-1-tert-butyl-3-(1’-naphthylmethyl)pyrazolo[3-4-d]pyrimidine) (Toronto Research Chemicals, Inc.; no. A603003) was added to a final concentration of 15 μM ...
• Multiple polarity kinases inhibit phase separation of F-BAR protein Cdc15 and antagonize cytokinetic ring assembly in fission yeast

  Rahul Bhattacharjee, et al., bioRxiv - Cell Biology 2022

  Quote: ... cells were grown in YES at 32°C to mid-log phase and treated with 4-amino-1-tert-butyl-3-(3-methylbenzyl)pyrazolo[3,4-3]pyrimidine (3MB-PP1) (Toronto Research Chemical; A602960 or Cayman Chemical; 17860) at a final concentration of 15 µM for 30 min ...